Abbott Laboratories 2015 Annual Report Download - page 32

Download and view the complete annual report

Please find page 32 of the 2015 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80

People around the world rely on the quality
of medications with Abbott’s name on the label
TRUSTED BRANDS
We’re helping more people in the
world’s fastest-growing economies
by bringing them high quality,
branded generic pharmaceuticals
that have been successfully
treating patients for years.
We’re tailoring our product
oerings to the specific needs
of the regions we serve, oering
new formulations, delivery
methods and packaging. Abbott
has leadership positions in many
of these geographies and is well
aligned with the fundamentals
driving long-term growth
for healthcare in these regions.
2015 BUSINESS HIGHLIGHTS
• Announced the creation of a pharmaceutical
development center in Rio de Janeiro, Brazil
• Advanced integrations of 2014 acquisitions, Veropharm
and CFR pharmaceuticals, strengthening Abbott’s
commercial, research, and manufacturing
infrastructure in Russia and Latin America, respectively
• Completed sale of Developed Markets pharmaceuticals
business to Mylan. Abbott is now completely focused on
faster-growing markets
• Gastroenterology
• Women’s Health
• Cardio-Metabolic
• Influenza Vaccine
• Pain/Central
Nervous System
• Respiratory/
Anti-Infectives
CORE THERAPEUTIC AREAS
ABBOTT 2015 ANNUAL REPORT
30
RESHAPED
FOR
ACCELERATED
GROWTH
ESTABLISHED
PHARMACEUTICALS
2015 Business Review